CULTZYME and Boehringer Ingeheim in the PHARMECO Project
We’re proud to celebrate the impactful role of the Cultzyme (CTZ) and Boehringer Ingelheim (BII) in the PHARMECO initiative—an ambitious Horizon Europe project advancing Safe and Sustainable by Design (SSbD) practices in pharmaceutical manufacturing.
Together as a key academic and industry partners, CTZ and BII bring deep scientific expertise and innovation to the table, particularly in:
🧪 Provide expertise in chemical & biological drug manufacturing
🤖 Deploy autonomous bioprocessing platform to shorten development timelines and reduce PMI
🌍 Set a new sustainability benchmark at PHARMECO
Their contributions are central to Work Package 4, which focuses on advance greener biomanufacturing practices by integrating innovative technologies, optimizing resource use, and enhancing process control .
👏 A huge thank you to the CTZ and BII teams for their dedication to building a more sustainable pharmaceutical future!
